Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001096906-17-000107
Filing Date
2017-02-17
Accepted
2017-02-17 12:32:39
Documents
71
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q AMENDMENT NO. 1 aoxing.htm 10-Q/A 559409
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SOX OF 2 exh31_1.htm EX-31.1 8388
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SOX OF 2 exh31_2.htm EX-31.2 8739
4 CERTIFICATE OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.SS.1350. exh32_1.htm EX-32.1 4950
5 CERTIFICATE OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.SS.1350. exh32_2.htm EX-32.2 4991
  Complete submission text file 0001096906-17-000107.txt   2817128

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT axn-20161231.xml EX-101.INS 539021
7 XBRL TAXONOMY EXTENSION SCHEMA axn-20161231.xsd EX-101.SCH 35019
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE axn-20161231_cal.xml EX-101.CAL 33228
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE axn-20161231_def.xml EX-101.DEF 53816
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE axn-20161231_lab.xml EX-101.LAB 170635
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE axn-20161231_pre.xml EX-101.PRE 153021
Mailing Address 1098 FOSTER CITY BLVD. SUITE 106-810 FOSTER CITY CA 94404
Business Address 1098 FOSTER CITY BLVD. SUITE 106-810 FOSTER CITY CA 94404 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
Type: 10-Q/A | Act: 34 | File No.: 001-32674 | Film No.: 17620533
SIC: 2834 Pharmaceutical Preparations